Rakesh Goel

2.0k total citations
95 papers, 1.5k citations indexed

About

Rakesh Goel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rakesh Goel has authored 95 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Rakesh Goel's work include Cancer Treatment and Pharmacology (33 papers), Colorectal Cancer Treatments and Studies (23 papers) and Gastric Cancer Management and Outcomes (12 papers). Rakesh Goel is often cited by papers focused on Cancer Treatment and Pharmacology (33 papers), Colorectal Cancer Treatments and Studies (23 papers) and Gastric Cancer Management and Outcomes (12 papers). Rakesh Goel collaborates with scholars based in Canada, United States and India. Rakesh Goel's co-authors include Stephen B. Howell, David J. Stewart, Nadia Z. Mikhael, S Kirmani, Farshad H. Shirazi, Lillian L. Siu, Mace L. Rothenberg, David Cunningham, Matilde Navarro and Simon Gollins and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Rakesh Goel

91 papers receiving 1.5k citations

Peers

Countries citing papers authored by Rakesh Goel

Since Specialization

Citations

This map shows the geographic impact of Rakesh Goel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Goel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Goel more than expected).

Fields of papers citing papers by Rakesh Goel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rakesh Goel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Goel. The network helps show where Rakesh Goel may publish in the future.

Co-authorship network of co-authors of Rakesh Goel

This figure shows the co-authorship network connecting the top 25 collaborators of Rakesh Goel. A scholar is included among the top collaborators of Rakesh Goel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakesh Goel. Rakesh Goel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Variable Endoscopist performance in proximal and distal adenoma detection during colonoscopy: a retrospective cohort study 2018 ·BMC Gastroenterology ·Paul D. James, (unknown), (unknown), Lilia Antonova, Alaa Rostom, Catherine Dubé, Sanjay K. Murthy, Rakesh Goel, Avijit Chatterjee	8
2	A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma 2018 ·Investigational New Drugs ·(unknown), Karen Mulder, Christine Brezden‐Masley, Michael M. Vickers, Jose Gerard Monzon, Hagen F. Kennecke, Rakesh Goel, Larissa J. Vos, Sunita Ghosh, (unknown), Anthony Fields, Jean A. Maroun, Jennifer L. Spratlin	1
3	Increased prevalence of colonic adenomas in patients with cystic fibrosis 2017 ·Journal of Cystic Fibrosis ·(unknown), Shawn D. Aaron, Paul D. James, Rakesh Goel, Avijit Chatterjee	8
4	A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium 2015 ·British Journal of Cancer ·Stéphanie Lheureux, Amit M. Oza, Scott A. Laurie, (unknown), Derek J. Jonker, (unknown), Deborah S. Keller, (unknown), Lily Wang, (unknown), Lillian L. Siu, Rakesh Goel	9
5	Estimation of genetic parameters of part lactation record in Sahiwal herd. 2012 ·Veterinary Practitioner ·(unknown), Rakesh Goel, (unknown), Pawanjit Singh	1
6	Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study 2008 ·Annals of Oncology ·Mace L. Rothenberg, John V. Cox, Charles Butts, Matilde Navarro, (unknown), Rakesh Goel, Simon Gollins, Lillian L. Siu, (unknown), David Cunningham	156
7	A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer 2005 ·Investigational New Drugs ·Mary J. MacKenzie, Holger W. Hirte, (unknown), (unknown), Rakesh Goel, Pierre Major, Wilson H. Miller, Lawrence Panasci, Ian A.J. Lorimer, Gerald Batist, S. Matthews, (unknown), Lesley Seymour	56
8	INTERACTION OF CISPLATIN WITH CELLULAR MACROMOLECULES: A FOURIER TRANSFORM INFRARED SPECTROSCOPY STUDY 2003 ·Iranian journal of pharmaceutical research ·Farshad H. Shirazi, (unknown), Rakesh Goel	8
9	Aspirin esterases in North-West Indians: the influence of age and nutrition 2000 ·International Journal of Clinical Pharmacology and Therapeutics ·(unknown), C K Nain, Monica Verma, (unknown), Rakesh Goel	2
10	Phase I-II Study of 5-Fluorouracil, Leucovorin, Doxorubicin, Methotrexate, and Long-Term Oral Etoposide (FLAME) in Unresectable or Metastatic Gastric Cancer 1998 ·American Journal of Clinical Oncology ·Georg A. Bjarnason, C. Cripps, Rakesh Goel, (unknown), Amit M. Oza, Jamey Skillings, Ian G. Kerr, Colin Germond, Malcolm J. Moore, Jean A. Maroun, Edmée Franssen, Hélène Dulude	0
11	Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer 1997 ·Cancer Chemotherapy and Pharmacology ·John Mathews, Rakesh Goel, William K. Evans, Farid M. Shamji, David J. Stewart	19
12	Cytotoxicity, Accumulation, and Efflux of Cisplatin and Its Metabolites in Human Ovarian Carcinoma Cells 1996 ·Toxicology and Applied Pharmacology ·Farshad H. Shirazi, J. Matshela Molepo, David J. Stewart, (unknown), G. P. Raaphorst, Rakesh Goel	19
13	The integrity of cisplatin in aqueous and plasma ultrafiltrate media studied by 195 Pt and 15 N nuclear magnetic resonance 1996 ·Cancer Chemotherapy and Pharmacology ·(unknown), Rakesh Goel, Farshad H. Shirazi, David J. Stewart, Ian C. P. Smith	16
14	Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin 1995 ·British Journal of Cancer ·DJ Stewart, J. Matshela Molepo, (unknown), V. Montpetit, Herman Hugenholtz, André Lamothe, (unknown), (unknown), Maria T. Gadia, Rakesh Goel	21
15	Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration 1994 ·Cancer Chemotherapy and Pharmacology ·David J. Stewart, Corinne Dulberg, J. Matshela Molepo, Nadia Z. Mikhael, (unknown), (unknown), Rakesh Goel	17
16	A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide 1993 ·British Journal of Cancer ·(unknown), Rakesh Goel, Paul A. Andrews, (unknown), S Kirmani, S. Kim, (unknown), Steven C. Plaxe, (unknown), Juan J. Alcaraz, (unknown)	10
17	Dose intensification of cisplatin chemotherapy through biweekly administration 1993 ·Annals of Oncology ·S. Kim, Stephen B. Howell, Edward F. McClay, S Kirmani, Rakesh Goel, Steven C. Plaxe, Patricia S. Braly, Andrea Bonetti	5
18	Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy 1990 ·European Journal of Cancer and Clinical Oncology ·Rakesh Goel, Paul A. Andrews, C E Pfeifle, Ian Abramson, S Kirmani, Stephen B. Howell	22
19	A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer. 1990 ·Journal of Clinical Oncology ·Stephen B. Howell, S Kirmani, William E. Lucas, Solomon Zimm, Rakesh Goel, (unknown), (unknown), (unknown), Julie Morris, Regis J. Weiss	35
20	Delayed erosion of intraperitoneal chemotherapy catheters into the bowel. Report of two cases 1989 ·Cancer ·R R Varney, Rakesh Goel, Eric vanSonnenberg, William E. Lucas, Giovanna Casola	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact